Long-term persistence of anti-HBs after hepatitis B vaccination among isolated anti-HBc positive adults in China: 8-years results

References

• World Health Organization. Global hepatitis report, 19 Apr 2017 [ OL]. [cited 2020 May 5]. https://www.who.int/publications-detail/global-hepatitis-report-2017.
   Google Scholar
• World Health Organization. Hepatitis B [OL]. 18 Jul 2019. [cited 2020 May 5]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
   Google Scholar
• Wang FZ, Zheng W, Su XJ, Miao N, Zhang GM, Yin ZD. Achievements and prospects for hepatitis B prevention and control in China. Chin J Vacc Immun. 2019;25:487–92. (In Chinese).
   Google Scholar
• Jing W, Liu J, Liu M. Eliminating mother-to-child transmission of HBV: progress and challenges in China. Front Med PMID: 31974872. 2020;14(1):21–29. doi:10.1007/s11684-020-0744-2.
   PubMed Web of Science ®Google Scholar
• Ren W, Ren JJ, Wu Z, Shen LZ, Shan H, Dai XW, Li J,Liu Y,Qiu Y, Yao J, et al. Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results. Hum Vaccin Immunother. 2020;16(3):687–92. doi:10.1080/21645515.2019.1666612. PMID: 31526223.
   PubMed Web of Science ®Google Scholar
• Liang XF, Bi SL, Yang WZ, Wang LD, Cui G, Cui FQ, Zhang Y, Liu J, Gong X, Chen Y, et al. Reprint of: epidemiological serosurvey of Hepatitis B in China–declining HBV prevalence due to Hepatitis B vaccination. Vaccine. 2013;31(Suppl 9):J21–8. doi:10.1016/j.vaccine.2013.08.012. PMID: 23948229.
   PubMed Web of Science ®Google Scholar
• Sunbul M, Leblebicioglu H, Esen S, Eroglu C, Barut S. Response to hepatitis B vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects. Scand J Infect Dis PMID: 10879605. 2000;32(3):315–16. doi:10.1080/00365540050165983.
   PubMedGoogle Scholar
• Kabir A, Keshvari M, Kashani AH, Alavian SM. Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs. Hum Vaccin PMID: 18398305. 2008;4(5):379–83. doi:10.4161/hv.4.5.6010.
   PubMed Web of Science ®Google Scholar
• Sunbul M, Leblebicioglu H, Esen S, Eroglu C, Barut S. Response to hepatitis B vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects. Scand J Infect Dis PMID: 10879605. 2000;32(3):315–16. doi:10.1080/00365540050165983.
   PubMedGoogle Scholar
• Greub G, Frei PC. Presence of low levels of anti-HBs antibody in so-called ‘anti-HBc alone’ subjects. Liver PMID:11903881. 2001;21(6):380–83. doi:10.1034/j.1600-0676.2001.210603.x.
   PubMedGoogle Scholar
• Moretto F, Catherine FX, Esteve C, Blot M, Piroth L. Isolated Anti-HBc: significance and management. J Clin Med PMID:31940817. 2020;9(1):202. doi:10.3390/jcm9010202.
   PubMed Web of Science ®Google Scholar
• Lok AS, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology PMID:2968954. 1988;8(4):766–70. doi:10.1002/hep.1840080411.
   PubMed Web of Science ®Google Scholar
• Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, et al. Serological pattern “anti-HBc alone”: report on a workshop. J Med Virol. 2000;62(4):450–55. doi:10.1002/1096-9071(200012)62:4<450::aid-jmv9>3.0.co;2-y. PMID:11074473.
   PubMed Web of Science ®Google Scholar
• Kang SY, Kim MH, Lee WI. The prevalence of “anti-HBc alone” and HBV DNA detection among anti-HBc alone in Korea. J Med Virol PMID: 20648604. 2010;82(9):1508–14. doi:10.1002/jmv.21862.
   PubMed Web of Science ®Google Scholar
• Morsica G, Bagaglio S, Spagnuolo V, Castagna A, Serio C, Galli A, Liviana DT, Andrea A, Alexander P. Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: results of a prospective Italian study. Plos One. 2017;12(9):e0184128. doi:10.1371/journal.pone.0184128. PMID:28863182.
   PubMed Web of Science ®Google Scholar
• Piroth L, Launay O, Michel ML, Bourredjem A, Miailhes P, Ajana F, Catherine C, David Z, Marre JW, Dani N, et al. Vaccination against Hepatitis B Virus (HBV) in HIV-1-infected patients with isolated anti-HBV core antibody: the ANRS HB EP03 CISOVAC prospective study. J Infect Dis. 2016;213(11):1735–42. doi:10.1093/infdis/jiw011. PMID:26768256.
   PubMed Web of Science ®Google Scholar
• Bahari A, Izadi S, Bari Z, Khosravi S, Baghaei B, Saneimoghadam E, Firouzi F, Espiari A, Esmaeilzadeh A, Mokhtarifar A, et al. Significance of response to hepatitis B recombinant vaccine in subjects with isolated antibody to hepatitis B core antigen. Middle East J Dig Dis. 2015;7(4):233–40. PMID: 26609352.
   PubMedGoogle Scholar
• Zhang L, Yan B, Lv J, Liu JY, Wu WL, Feng Y, Xu AQ. Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: results from a three-year follow-up study in China. Vaccine. 2018;36(16):2207–12. doi:10.1016/j.vaccine.2018.02.039. PMID:29548609.
   PubMed Web of Science ®Google Scholar
• Yao J, Ren W, Chen YD, Jiang ZG, Shen LZ, Shan H, Dai XW, Li J, Liu Y, Qiu Y, et al. Responses to hepatitis B vaccine in isolated anti-HBc positive adults. Hum Vaccin Immunother. 2016;12(7):1847–51. doi:10.1080/21645515.2016.1139256. PMID: 27065099.
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Dentinger CM, Bruden D, Lisa B, Anthory EF, Beth PB, Thomas WH, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis. 2009;200(9):1390–96. doi:10.1086/606119. PMID:19785526.
   PubMed Web of Science ®Google Scholar
• Hyun CS, Lee S, Ventura WR. The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population. BMC Res Notes PMID: 31060623. 2019;12(1):251. doi:10.1186/s13104-019-4287-z.
   PubMedGoogle Scholar
• Koh HJ, Kim SD, Choi JH, Kim SR, Lee JS. A study of immune response to hepatitis B vaccine & HBV DNA in isolated anti-HBc positive subjects. J Prev Med Public Health. 2005;38(2):170–74. PMID: 16315754.
   PubMedGoogle Scholar
• Silva AE, McMahon BJ, Parkinson AJ, Sjogren MH, Hoofnagle JH, Di BAM. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis. 1998;26(4):895–97. doi:10.1086/513918. PMID: 9564471
   PubMed Web of Science ®Google Scholar
• Shim J, Kim KY, Kim BH, Chun H, Lee M, Hwangbo Y, Jae YJ, Seok HD, Hyo JK, Young WC, et al. Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers. Vaccine. 2011;29(8):1721–26. doi:10.1016/j.vaccine.2010.11.044. PMID: 21147128.
   PubMed Web of Science ®Google Scholar
• Chan CY, Lee SD, Tsai YT, Lo KJ. Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc. J Gastroenterol Hepatol PMID:7787166. 1995;10(2):192–97. doi:10.1111/j.1440-1746.1995.tb01077.x.
   PubMed Web of Science ®Google Scholar
• Chang JJ, Mohtashemi N, Bhattacharya D. Significance and management of isolated Hepatitis B core antibody (Anti-HBc) in HIV and HCV: strategies in the DAA Era. Curr HIV/AIDS Rep PMID:29572624. 2018;15(2):172–81. doi:10.1007/s11904-018-0379-y.
   PubMed Web of Science ®Google Scholar
• Li H, GJ L, Chen QY, Fang ZL, Wang XY, Tan C, Yang QL, Wang FZ, Zhang S, Bi SL, et al. Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed. Epidemiol Infect. 2017;145(5):887–94. doi:10.1017/S0950268816003046. PMID:28065199.
   PubMed Web of Science ®Google Scholar
• Van Damme P, Dionne M, Leroux-Roels G, Meeren O, Paolo E, Salaun B, Pemmaraju SK, Nicalas F. Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults. J Viral Hepat. 2019;26(9):1066–75. doi:10.1111/jvh.13125. PMID: 31087382.
   PubMed Web of Science ®Google Scholar
• Katz L, Strong DM, Tegtmeier G, Stramer S. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Transfusion (Paris) PMID:18647367. 2008;48(11):2315–22. doi:10.1111/j.1537-2995.2008.01844.x.
   Web of Science ®Google Scholar